Chandler, AZ, United States of America

Kandavel Shanmugam

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Chandler, AZ (US) (2020 - 2023)
  • Oro Valley, AZ (US) (2023)

Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):

Title: Kandavel Shanmugam: Innovating in the Field of Biomedical Technology

Introduction:

Throughout his career, Kandavel Shanmugam has made significant contributions to the field of biomedical technology with his exceptional expertise and innovative mindset. Working with leading companies in the technology sector, Shanmugam has played a pivotal role in the development of cutting-edge patents that have advanced the field of medical diagnostics and treatment.

Latest Patents:

Supporting advancements in the field of cancer research, Kandavel Shanmugam's latest patents are focused on evaluating immune cell infiltrate in tumor samples and developing histochemical assays for human pro-epiregulin and amphiregulin. These patents introduce novel methods and systems that aid in the evaluation of tumor tissue samples, allowing medical professionals to make more informed diagnostic and treatment decisions based on immune context scores.

Career Highlights:

Throughout his career, Shanmugam has worked with prominent companies, including Ventana Medical Systems, Inc. and Oregon Health & Science University. His contributions have been marked by his ability to develop groundbreaking solutions and techniques in the field of biomedical technology. With a total of seven patents to his name, Shanmugam's expertise shines through his ability to integrate immuno-oncology and biomedical assays, bringing forth significant advancements in the field.

Collaborations:

In his professional journey, Kandavel Shanmugam has had the opportunity to collaborate with esteemed individuals in the industry. Notably, he has worked alongside Michael S Barnes and David Chafin, fostering a collaborative atmosphere that encourages the exchange of ideas and the pursuit of groundbreaking inventions.

Conclusion:

Kandavel Shanmugam's contributions to the field of biomedical technology have been nothing short of exceptional. Through his innovative patents and collaborative efforts, he has paved the way for advancements in cancer research, specifically in the evaluation of immune cell infiltrate in tumor samples and the development of histochemical assays. Shanmugam's commitment to pushing the boundaries of medical diagnostics and treatment is commendable, and his work continues to have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…